What is the recommended dose of benzonatate for an adult patient with acute cough and a history of cardiovascular disease, currently taking Plavix (clopidogrel)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benzonatate Dosing for Acute Cough

For acute cough in adults, benzonatate should be dosed at 100-200 mg three times daily as needed, with a maximum of 600 mg per day in three divided doses, and there are no known drug interactions between benzonatate and clopidogrel (Plavix), making concurrent use safe. 1

Standard Dosing Regimen

  • The FDA-approved dose is 100-200 mg capsules three times daily as needed for cough 1
  • If necessary to control cough, up to 600 mg daily in three divided doses may be given 1
  • Capsules must be swallowed whole and should never be broken, chewed, dissolved, cut, or crushed 1

Critical Safety Considerations

Swallowing Instructions:

  • Breaking or chewing benzonatate capsules can cause release of the medication in the mouth, producing temporary local anesthesia of oral mucosa and potential choking 1
  • If numbness or tingling of the tongue, mouth, throat, or face occurs, patients must refrain from eating or drinking until numbness resolves 1

Overdose Risk:

  • Overdosage resulting in death may occur in adults 1
  • Do not exceed a single dose of 200 mg or total daily dosage of 600 mg 1
  • Signs of overdose (restlessness, tremors, convulsions, coma, cardiac arrest) have been reported within 15-20 minutes, with death occurring within one hour of ingestion 1

Compatibility with Plavix (Clopidogrel)

There are no documented drug interactions between benzonatate and clopidogrel. Benzonatate is chemically related to para-amino-benzoic acid class anesthetic agents (procaine, tetracaine) and works as a peripherally-acting local anesthetic on the respiratory tract 1. Clopidogrel is metabolized primarily by CYP2C19 hepatic enzymes and works through ADP-dependent platelet inhibition 2, 3. These distinct mechanisms and metabolic pathways mean concurrent use is safe.

Clinical Context for Use

  • Benzonatate is recommended as a local anesthetic option for opioid-resistant cough that does not respond to peripheral antitussives 4
  • The CHEST guidelines suggest benzonatate as a trial option alongside nebulized lidocaine/bupivacaine for difficult-to-control cough 4
  • Benzonatate is positioned as a later-line therapy, not first-line treatment for acute cough 4

Common Pitfalls to Avoid

  • Never prescribe benzonatate to children under 10 years of age - accidental ingestion has resulted in death in this population 1
  • Ensure patients understand the critical importance of swallowing capsules whole 1
  • Keep benzonatate out of reach of children, as fatal overdose can occur rapidly 1
  • Assess for prior sensitivity to related anesthetic agents (procaine, tetracaine) before prescribing 1

Cardiovascular Disease Considerations

For patients with cardiovascular disease on clopidogrel:

  • Continue clopidogrel as prescribed - it is essential for preventing thrombotic events in patients with established cardiovascular disease 5, 3
  • Benzonatate can be safely added without concern for drug interactions
  • The standard benzonatate dosing of 100-200 mg three times daily applies regardless of cardiovascular comorbidities 1

References

Research

CYP2C19 genetic variation and individualized clopidogrel prescription in a cardiology clinic.

Journal of community hospital internal medicine perspectives, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

The Cochrane database of systematic reviews, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.